<DOC>
	<DOCNO>NCT01931683</DOCNO>
	<brief_summary>The investigator attempt determine optimal effect-site concentration remifentanil smooth removal LMA propofol anesthesia .</brief_summary>
	<brief_title>Dosing Study Remifentanil Smooth Removal Laryngeal Mask Airway ( LMA )</brief_title>
	<detailed_description>At end surgery , propofol infusion stop remifentanil titrate predetermine ( initial concentration 1.0 ng/ml first patient ) . LMA removal perform patient open eyes spontaneous respiration adequate tidal volume ventilatory frequency confirm .</detailed_description>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<criteria>ASA III patient undergo general anesthesia short elective surgery ( &lt; 1 hr ) GE reflux obesity ( BMI &gt; 30 ) anticipate difficult airway</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>LMA removal</keyword>
	<keyword>remifentanil</keyword>
	<keyword>propofol</keyword>
</DOC>